Emergent BioSolutions | EBS - Eps Ganancias Por Acción

Precio De Mercado
8.07
Cambio Diario
-0.06 -0.74%
Mensual
-25.48%
Anual
46.46%
Q1 Expectativa
7.88




Eps Cambio Fecha
Acadia Pharmaceuticals USD 1.6 1.18 2025-12
Akebia Therapeutics USD 0.03 0.13 2025-03
ALKERMES USD 0.29 0.2 2025-12
Alnylam Pharmaceuticals USD 1.25 1.65 2025-12
Amarin USD 0.08 0.11 2025-09
ANI Pharmaceuticals USD 2.33 0.29 2025-12
BioMarin Pharmaceutical USD 0.46 0.34 2025-12
Coherus Biosciences USD -0.35 0.07 2025-03
Emergent BioSolutions USD -0.77 0.29 2023-12
Exact Sciences USD -0.45 0.69 2025-12
Exelixis USD 0.97 0.19 2025-12
Glaxosmithkline GBP 0.72 0.37 2025-09
Heron Therapeutics USD -0.03 0.03 2024-09
Ionis Pharmaceuticals USD -1.41 0.61 2025-12
Ironwood Pharmaceuticals USD -0.01 0.25 2025-12
Lexicon Pharmaceuticals USD -0.17 0.02 2024-06
Lonza CHF 6.07 1.92 2025-06
Merck USD 2.04 0.54 2025-12
Moderna USD -2.11 1.6 2025-12
Myriad Genetics USD 0.04 0.01 2025-12
Nektar Therapeutics USD -0.18 0.07 2024-09
Neurocrine Biosciences USD 1.88 0.29 2025-12
Pacira USD 0.06 0.64 2025-12
Pfizer USD 0.66 0.21 2025-12
PTC Therapeutics USD -1.67 1.87 2025-12
Sanofi EUR 1.53 1.38 2025-12
Sarepta Therapeutics USD -3.58 3.45 2025-12
United Therapeutics USD 7.7 0.54 2025-12
Vanda Pharmaceuticals USD -0.09 0 2024-12
Xoma USD -1.59 2.43 2024-09